SNU CBE

Arginine-Rich Manganese Silicate Nanobubbles as a Ferroptosis-Inducing Agent for Tumor-Targeted Theranostics

2018 · ACS Nano

저자

Shuaifei Wang, Fangyuan Li, Ruirui Qiao, Xi Hu, Hongwei Liao, Lumin Chen, Jiahe Wu, Haibin Wu, Meng Liang Zhao, Jianan Liu, Rui Chen, Xibo Ma, Dokyoon Kim, Jihong Sun, Thomas Paul Davis, Chunying Chen, Jie Tian, 현택환 (Taeghwan Hyeon), Daishun Ling

연구주제

Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery

NTIS 과학기술표준분류

가장 가까운 분류(보건의료 > 신약·의약품개발 > 약물전달시스템)가 화학·화공 범위 밖이다. 배정 근거: AI 키워드가 잡은 NTIS 과제의 분류.

AI 연구 키워드·방법

페롭토시스 glutathione depletion manganese silicate nanobubble 테라노스틱(진단·치료 겸용) 나노입자

키워드 (OpenAlex)

ferroptosis glutathione depletion on-demand drug release reactive oxygen species iron-based nanomaterials cancer therapy

초록

Ferroptosis, an iron-based cell-death pathway, has recently attracted great attention owing to its effectiveness in killing cancer cells. Previous investigations focused on the development of iron-based nanomaterials to induce ferroptosis in cancer cells by the up-regulation of reactive oxygen species (ROS) generated by the well-known Fenton reaction. Herein, we report a ferroptosis-inducing agent based on arginine-rich manganese silicate nanobubbles (AMSNs) that possess highly efficient glutathione (GSH) depletion ability and thereby induce ferroptosis by the inactivation of glutathione-dependent peroxidases 4 (GPX4). The AMSNs were synthesized via a one-pot reaction with arginine (Arg) as the surface ligand for tumor homing. Subsequently, a significant tumor suppression effect can be achieved by GSH depletion-induced ferroptosis. Moreover, the degradation of AMSNs during the GSH deplet…

이 논문을 지원한 국가R&D 과제 (NTIS 성과)

NTIS 성과DB(2020–24)에서 DOI 매칭 없음

인접 그래프

노드 hover = 이웃 강조 · 1회 클릭 = 고정 · 고정된 노드 다시 클릭 = 페이지 이동

이 문서와 연결된 페이지

교수 1

현택환

연구주제 1

Nanoplatforms for cancer theranostics

키워드 2

테라노스틱(진단·치료 겸용) 나노입자 · 페롭토시스